Assertio Holdings (ASRT) Revenue (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Revenue came in at $9.9 million in Q1 2026, down 62.5% year-on-year from $26.5 million in Q1 2025, and down 26.65% quarter-over-quarter from $13.5 million in Q4 2025.
Assertio Holdings (ASRT) Revenue (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Revenue across 8 years of filings, most recently posting $9.9 million for Q1 2026.
- Revenue for Q1 2026 came in at $9.9 million, down 62.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $102.2 million (down 14.16% YoY), and the FY2025 annual result was $118.7 million, down 5.0% from the prior year.
- Revenue came in at $9.9 million for Q1 2026 at Assertio Holdings, down from $13.5 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $50.3 million in Q4 2022 to a low of $9.9 million in Q1 2026.
- The 5-year median for Revenue is $33.0 million (2023), against an average of $33.1 million.
- Across the five-year window, Revenue soared 69.36% in 2025 and plunged 62.5% in 2026, its largest moves.
- Assertio Holdings' Revenue stood at $50.3 million in 2022, then slumped by 34.49% to $33.0 million in 2023, then declined by 2.43% to $32.2 million in 2024, then slumped by 57.92% to $13.5 million in 2025, then decreased by 26.65% to $9.9 million in 2026.
- The last three Revenue figures came in at $9.9 million (Q1 2026), $13.5 million (Q4 2025), and $49.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 377.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 608.10 Mn |
| 10 | Assertio Holdings | 150.78 Mn | 79.21 Mn | 7.22 Mn | 9.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.93 Mn |
| Dec 31, 2025 | 13.54 Mn |
| Sep 30, 2025 | 49.46 Mn |
| Jun 30, 2025 | 29.22 Mn |
| Mar 31, 2025 | 26.49 Mn |
| Dec 31, 2024 | 32.18 Mn |
| Sep 30, 2024 | 29.20 Mn |
| Jun 30, 2024 | 31.13 Mn |
| Mar 31, 2024 | 32.45 Mn |
| Dec 31, 2023 | 32.99 Mn |
| Sep 30, 2023 | 35.63 Mn |
| Jun 30, 2023 | 40.99 Mn |
| Mar 31, 2023 | 42.47 Mn |
| Dec 31, 2022 | 50.35 Mn |
| Sep 30, 2022 | 34.21 Mn |
| Jun 30, 2022 | 35.13 Mn |
| Mar 31, 2022 | 36.54 Mn |
| Dec 31, 2021 | 33.33 Mn |
| Sep 30, 2021 | 25.47 Mn |
| Jun 30, 2021 | 25.37 Mn |